Study details
Enrolling now
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
VIVUS LLC
NCT IDNCT06915246ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
49
Study length
about 1.1 years
Ages
18+
Locations
4 sites in AZ, CA, GA +1
About this study
Researchers are testing a treatment (VI-0609) compared to another treatment (BiCNU) for lymphoma. The trial will last about 414 days, involving approximately 49 participants.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take BiCNU
- 2.Take VI-0609
PhasePhase 2
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Oncology